Study of Antidiabetic Activity on Averrhoa Carambola Leaves by Muhamed Shanoof, M
STUDY OF ANTIDIABETIC ACTIVITY ON AVERRHOA 
CARAMBOLA LEAVES      
 
Project Proposal submitted to 
The Tamil Nadu Dr.M.G.R Medical University Chennai 
In partial fulfillment of the degree of 
MASTER OF PHARMACY 
(Pharmacology) 
Submitted by 
 MUHAMED SHANOOF N.P 
(Reg No :261526159) 
Under the guidance of 
Dr. C. SENTHIL KUMAR, M.Pharm., Ph.D 
Associated Professor  
Department of Pharmacology 
Karpagam College of Pharmacy 
Coimbatore-32 
 
SEPTEMBER 2017 
DEPARTMENT OF PHARMACOLOGY 
KARPAGAM COLLEGE OF PHARMACY 
COIMBATORE-641 032 
 
CERTIFICATE 
 
This is to certify that this dissertation entitled “STUDY OF ANTIDIABETIC 
ACTIVITY ON AVERRHOA CARAMBOLA LEAVES” Submitted by Mr. 
MUHAMED SHANOOF N.P to The Tamil Nadu Dr.M.G.R Medical University, 
Chennai in partial fulfilment for the degree of Master of Pharmacy in Pharmacology 
is a bonafied work carried out by the candidate under the guidance and supervision of 
Dr.C. Senthil Kumar M.Pharm., Ph.D in the Department of Pharmacology, Karpagam 
College of Pharmacy Coimbatore-32. 
I have fully satisfied with his performance and work. I have forward this 
dissertation work for evaluation. 
 
 
 
 
 
 
Place  :                                                              Dr. S. MOHAN M.Pharm., Ph.D., 
Date    :                                                             Principal 
                                                          
 
 
                                                                                
                                                                                                                                                                                                              
 
 
 
CERTIFICATE 
 
This is to certify that this dissertation entitled “STUDY OF ANTIDIABETIC 
ACTIVITY ON AVERRHOA CARAMBOLA LEAVES” Submitted by Mr. 
MUHAMED SHANOOF N.P to The Tamil Nadu Dr.M.G.R Medical University, 
Chennai in partial fulfilment for the degree of Master of Pharmacy in Pharmacology 
is a bonafied work carried out by the candidate under the guidance and supervision of 
Dr .C. Senthil Kumar M.Pharm., Ph.D in the Department of Pharmacology, Karpagam 
College of Pharmacy Coimbatore-32. 
 
 
 
 
 
 
 
Place  :                                                              Prof.G. NAGARAJAPERUMAL 
Date    :                                                             Head of the Department 
                                                                          Department of Pharmacology 
 
 
 
 
 
 
 
 
CERTIFICATE 
 
 This is to certify that this dissertation entitled entitled “STUDY OF 
ANTIDIABETIC ACTIVITY ON AVERRHOA CARAMBOLA LEAVES” 
submitted by Mr. MUHAMED SHANOOF N.P to The Tamil Nadu Dr.M.G.R 
Medical University, Chennai in partial fulfilment for the degree of Master of 
Pharmacy in Pharmacology is a bonafied work carried out under my guidance and 
supervision in the Department of Pharmacology, Karpagam College of Pharmacy 
Coimbatore-32. 
  
 
 
 
Place:                                                                    Dr. C. SENTHIL KUMAR, M.Pharm., Ph.,D                                                                                            
Date :                                                                    Associate Professor 
                                                                           Karpagam College of Pharmacy 
 
 
 
  
                                                                                                                   
                                                                     
                     
 
 
  
CERTIFICATE 
 
 This is to certify that this dissertation entitled “STUDY OF ANTIDIABETIC 
ACTIVITY ON AVERRHOA CARAMBOLA LEAVES” submitted by Mr. 
MUHAMED SHANOOF N.P to the Tamil Nadu Dr. M.G.R Medical University, 
Chennai in partial fulfilment for the degree of Master of Pharmacy in Pharmacology 
is a bonafied work carried out by the candidate under my guidance at SURAS 
LABORATORIES, during the academic year 2016-2017. 
 
 
 
Place   :                                                                                     Dr. P. Krantikumar   
Date    :                                                                                               Co-guide                                                                                                                                                                                                                                                                                                                  
                                                                       
                                                                                                               
 
 
 
 
 
 
 
 
 
 
DECLARATION 
 
  I hereby declare that this dissertation entitled “STUDY OF ANTIDIABETIC 
ACTIVITY ON AVERRHOA CARAMBOLA LEAVES” submitted by me, in partial 
fulfilment of the requirements for the degree of Master of Pharmacy  in  
Pharmacology to The Tamil Nadu Dr. M.G.R Medical university, Chennai is the result 
of my original and independent research work carried out under the guidance of    Dr. 
C. SENTHIL KUMAR M.Pharm.,Ph.D  Associate Professor, Department of 
Pharmacology, Karpagam College of Pharmacy, Coimbatore-32, & Co-Guide Dr. P. 
KRANTIKUMAR, Suras Laboratories,   during the academic year 2016- 2017. 
 
 
 
 
Place :                                                                      Mr. MUHAMED SHANOOF N.P 
 
Date:                                                                                              
 
 
 
 
 
 
 
 
                                                 
                                     
EVALUATION CERTIFICATE 
 
  This is to certify that the dissertation work “STUDY OF ANTIDIABETIC 
ACTIVITY ON AVERRHOA CARAMBOLA LEAVES” submitted by, Mr. 
SHANOOF N.P bearing Reg.No: 261526159 to The Tamil Nadu Dr. M. G. R Medical 
University, Chennai in partial fulfilment for the Degree of Master of Pharmacy in 
Pharmacology is a bonafied work carried out during the academic year 2016-2017 by 
the candidate at Department of Pharmacology, Karpagam College of Pharmacy, 
Coimbatore and was evaluated by us. 
 
Examination centre: 
Date: 
 
 
 
Internal Examiner                                                          Convener of Examination 
 
 
                                                   External examiner 
 
 
 
 
 
                                  
ACKNOWLEDGEMENT 
 
At first I bow to my GOD, who inspires for the beginning and completion of 
every effort for a good work. I hereby take this opportunity to acknowledge all those 
who have helped us in the completion of this dissertation work. 
 We express our extended thanks to our most respected Chairman and respected 
trustee Dr.R.Vasanthakumar, Karpagam Educational Trust, for the facilities provided   
to carry out this project.  
My sincere thanks to our respected and beloved Principal                                          
Dr. S. MOHAN, M. Pharm, Ph.D., Karpagam College of Pharmacy for his 
encouragement and also providing all  facilities in this institutions to the fullest possible 
extent enabling me to complete this work successfully. 
It is my pleasure to express my honorable thanks to Prof. G. 
NAGARAJAPERUMAL, M. Pharm, Professor & Head, Deportment of 
Pharmacology, Karpagam College of Pharmacy.who helped us carried out the 
validation and degradation studies related to our project. 
  I would like to take this opportunity in expressing my deep sense of gratitude to 
my beloved guide Dr. C. SENTHIL KUMAR M. Pharm., Ph.D  Associate Professor, 
Department of Pharmacology, Karpagam College of Pharmacy under whose active 
guidance, Innovative ideas, constant inspiration and encouragement of the work 
entitled, “STUDY OF ANTIDIABETIC ACTIVITY ON AVERRHOA 
CARAMBOLA LEAVES” has been carried out. 
I convey my gratitude to Dr.  V. E. IDACHRISTI, M. Pharm, Ph.D., 
Professor & Head Department of Pharmacognosy, Helped me to proceed useful ideas. 
I am also convey my thanks to Dr. M. KARPAGAVALLI, M. Pharm, Ph.D., 
Professor  & Head Department of Pharmaceutical Chemistry, for encouragement and 
valuable suggestion during this work. 
It is my pleasure to express my honorable thanks to Dr. S. JANARDHANAN, 
M. Pharm., Ph.D., Professor Department of Pharmacognosy, helped me to proceed 
project work. 
It is my pleasure to express my honorable thanks to Mr. A. MUTHUKUMAR, 
M. Pharm, Asst. Professor, Department of Pharmacology, helped me to proceed 
project work. 
My whole hearted thanks to Mr. D. RANJITH KUMAR, M. Pharm, Asst. 
Professor, Department of Pharmaceutical Analysis for his kind advice. 
I convey my gratitude to Mrs. MARY PRIYA, M. Pharm. Asst. Professor 
Department of Pharmacy Practice, Helped me to given useful ideas. 
I convey my thanks to Ms M. SATHYA., Lab Assistant, Department of 
Pharmacology for his kind support. 
I express my sincere thanks to Mr. K. SIMON, Lab Assistant, Department of 
Pharmaceutical Chemistry for his kind support. 
I convey my gratitude thanks to Mr. S. ANTONY DAS, Lab Assistant, 
Department of Pharmaceutics for his kind support. 
I am duly bound to all my nonteaching staffs of Karpagam College of Pharmacy 
for their valuable and co operation  
 
 
 Mr. MUHAMED SHANOOF N.P  
 
 
 
 
 
TABLE OF CONTENTS 
 
S.No 
 
Contents 
 
Page No. 
1 Introduction 
1-18 
2 Review of Literature 
19-31 
3 Aim and Objective 
32 
4 Plan of Work 
33 
6 Materials and Methods 
34-40 
6 Results& Discussion  
41-60 
7 Summary  
61 
8 Conclusion 
62 
9 References                                                                                  
63-66 
10 Appendix 67 
                               LIST OF TABLES 
S. No. Title Page No. 
1 
WHO diabetes Information chart 10 
2 
Oral antihyperglycemics 12 
3 List of pharmacologically tested anti-diabetic plant 
materials in steptozotocin induced diabetic animal 
model Plant Name 
16-17 
4 α-Amylase Inhibition of Petroleum Ether extract of   
Averrhoa carambola leaves 
42 
5 α-Amylase Inhibition of  Ethyl acetate Extract of 
Averrhoa carambola leaves 
44 
6 α-Amylase Inhibition of  Ethanolic Extract of 
Averrhoa carambola leaves 
45 
7 
α-Amylase Inhibition  of Acarbose  (Positive control) 47 
8 Phytochemical studies 
48 
9 
Hypoglycemic Test 50 
10 
Invivo antidiabetic study 53 
11 
Oral Glucose Tolerance Test 56 
 
 
  
LIST OF FIGURES 
S. No. TITLE 
Page 
No. 
1 
Main Symptoms of Diabetes 5 
2 
Fate of Type-II diabetes 6 
3 
Oral antidiabetic agents site of action 9 
4 
Classification of Sulphonyl Ureas 14 
5 
Leaves of Averrhoa carambola[ 30 
6 
Fruits of Averrhoa carambola 31 
7 
Fruits and stems of Averrhoa carambola 31 
8 Alpha-amylase Inhibition of Petroleum ether extract of 
Averrhoa carambola leaves 
43 
9 Graphical representation of Alpha-amylase Inhibition of 
Petroleum ether extract of Averrhoa carambola leaves 
43 
10 Alpha-amylase Inhibition of Ethyl acetate extract of Averrhoa 
carambola leaves 
44 
11 Graphical representation of Alpha-amylase Inhibition of Ethyl 
acetate extract of Averrhoa carambola leaves 
45 
12 Alpha-amylase Inhibition of Ethanolic extract of Averrhoa 
carambola leaves 
46 
13 Graphical representation of Alpha-amylase Inhibition of 
Ethanolic extract of Averrhoa carambola leaves 
46 
14 
Alpha-amylase Inhibition of positive control 47 
15 Graphical representation of alpha-amylase Inhibition of positive 
control 
48 
16 
Extract to cause percentage Inhibition 49 
17 
Hypoglycemic effect initial 51 
  
 
 
  
18 
Hypoglycemic effect 30 minutes 51 
19 
Hypoglycemic effect 1 hour 52 
20 Results of the effects of ethanolic extract on blood Glucose 
levels at day 1 
54 
21 Results of the effects of ethanolic extract on blood Glucose 
levels at day 7 
54 
22 Results of the effects of ethanolic extract on blood Glucose 
levels at day 14 
55 
23 
Oral glucose tolerance test initial 57 
24 
Oral glucose tolerance test 57 
25 
Oral glucose tolerance test  one hourly 58 
26 
OGTT Oral glucose tolerance test  1.5 hourly 58 
27 
Oral glucose tolerance test  2.0 hourly 59 
28 
Oral glucose tolerance test  2.5 hourly 59 
29 
Oral glucose tolerance test 3.0 hourly 60 
LIST OF ABBRIVATION 
S.No Short form Full form 
1  OGTT Oral glucose tolerance test 
2  WHO World health organisation 
3  CE Conformity European 
4  NPH Natural protamine hagedorn 
5  IDF Intermediate distribution frame  
6  HBA1C Haemoglobin although one chemical 
7  ACELs Angiotensin converting enzyme inhibitors 
8  ARBs Angiotensin receptor blockers  
9  HDL High density lipoprotein 
10  A1C Although one chemical 
11  AA Antioxidant activity 
12  TFC Total flavonoid content 
13  TPC Total phenolic content 
14  DPPH -2,2-di phenyl-1-picrylhydrazyl  
15  BCB -β carotene bleaching 
16  FRAP Ferric reducing antioxidant  power 
17  EC50 Effective concentration 
18  TE/g Totally enclosed 
19  SEM Scanning electron microscope 
20  ANOVA Analysis of variance 
21  IC50 Inhibitory concentration 
22  HELAC Hydro alcoholic extract of leaves of averrhoa carambola 
23  C14 Carbon 
24  MPO Myeloperoxidase 
25  ID50  Infection dose 
26  HCC Hepatocellular carcinoma 
27  DENA Diethyl nitrosamine 
28  ACE Angiotensin converting enzyme 
29  CCL4 Carbon tetra chloride 
30  HCL Hydrochloride 
31  OECD Organisation for economic cooperation and 
development 
32  LD50 Lethal dose 
33  OAEC Organisation of animal ethics committee 
34  CMC Carboxy methyl cellulose 
35  PO Per oral 
36  IP Intra peritoneal 
 
Department Of Pharmacology, Karpagam College Of Pharmacy     Page 1 
 
1. INTRODUCTION 
Diabetes mellitus (DM) is a collection of metabolic issue described by hyperglycemia; 
is related with variations from the normal sugar, fat and protein digestion; and results in 
incessant intricacies including microvascular, macrovascular, and neuropathic disorders1. It 
is in recent times evaluated that no less than 171 million individuals worldwide have 
diabetes, and this figure is probably going to dramatically increase by 2030. Additionally, 
around 3.2 million passings consistently are owing to difficulties of diabetes; six passings 
each minute. Aside from presently accessible helpful alternatives like insulin, 
sulfonylureas, biguanides, thiazolidinediones etc, numerous home grown drugs have been 
prescribed for the treatment of diabetes because of their lesser symptoms and expanded 
agreeableness. Presently a day, there are various plants which are known for their 
antidiabetic potential. All through the world numerous conventional plant medicines for 
diabetes exist2. Nonetheless, few have gotten logical or medicinal investigation and the 
WHO has suggested that conventional plant medications for diabetes warrant facilitate 
evaluation.  
Indian physicians around the same time identified the disease and classified it 
as Madhumeha or "honey urine", noting but the urine would attract ants. This is possibly 
due to the diet and life-style of the ancient people, or because the clinical symptoms were 
observed during the advanced stage of the disease. Galen named the disease "Diarrhea of 
the urine" (diarrhea urinosa). The earliest surviving work with a detailed reference to 
diabetes is that of Aretaeus of Cappadocia (2nd or early 3rd century CE). Type 1 and type 2 
diabetes were identified as separate conditions for the first time by the Indian physicians 
Sushruta and Charaka in 400-500 CE with type 1 associated with youth and type 2 with 
being overweight. Effective treatment was not developed until the early part of the 20th 
century, when Canadians Frederick Banting and Charles Herbert Best isolated and purified 
insulin in 1921 and 1922.  This was followed by the development of the long-acting insulin 
NPH in the 1940s. Medicinal plants constitute an important natural wealth of a country. 
They play a significant role in providing primary health care services to the rural 
population. They serve as therapeutic agents as well as important raw materials for the 
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manufacture of traditional medicines. Ethno pharmacology is the study of plants used in 
traditional medicine and is therefore heavily reliant on interactions between researchers and 
indigenous communities who passed on the traditional knowledge over generations. Whilst 
in the main, ethno pharmacology focuses on the presence or absence of evidence for 
specific therapeutic responses through the use of herbal remedies, the field also extends 
into phytochemistry where the aim is to identify the chemical constituent of the plant or 
plant extract that is responsible for the pharmacological activities inherent to a specific 
plant.  
In the last few years there has been an exponential growth in the field of herbal 
medicine and these drugs are gaining popularity both in developing and developed 
countries because of their natural origin and less side effects. Many traditional medicines in 
use are derived from medicinal plants, minerals and organic matter. WHO has listed 21,000 
plants, which are used for medicinal purposes around the world. Therefore, with the rising 
number of diseases lately, many researchers have evaluated the medicinal plants as 
alternative therapeutic agents. The effectiveness and safety of drugs derived from 
medicinal plants require scientific evaluation to establish the profiles of therapeutic 
effectiveness and toxicity of plant products. One example of such products is 
antihyperglycemic agents for use in the treatment of diabetes mellitus.  
 
Importance of medicinal plants and traditional medicines  
Medicinal plants, since time immemorial, have been used in virtually all cultures as 
a source of medicine. It has been estimated that about 80-85% of population both in 
developed and developing countries rely on traditional medicine for their primarily health 
care needs and it is assumed that a major part of traditional therapy involves the use of 
plant extracts or their active principles. Due to lack of organized health care systems in 
developing countries like Ethiopia, people with chronic diseases like diabetes are among 
the worst suffers in their communities today. Hence, most of the populations still have 
limited access or no access, especially those in remote areas, to modern medicines. Instead 
they use traditional medicines for a range of diabetic complications. 
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Diabetes mellitus  
Diabetes mellitus is described as metabolic disorder which resulting from defects in 
insulin secretion or insulin action or both diabetes mellitus could cause long-term damage, 
dysfunction and failure in many organs. Patients with diabetes can develop heart disease, 
kidney disease, and blindness, vascular or neurological problems that can lead to 
amputation and can suffer increased rates of mortality. Moreover, the death rate in patients 
with diabetes is much higher than in persons without the disease. According to the 
estimation of the International Diabetes Federation (IDF), one among ten adults would 
have diabetes by 2030. There were 366 million people having diabetes in 2011; this will 
increase to 552 million people by 2030.  
The number of people got type 2 diabetes is increasing every year and many people remain 
un-diagnostic. In the demand of preventing and treating Diabetes Mellitus, there are many 
synthetic drugs have been researched and developed such as Sulphonylureas, 
thiazolidinediones, Glinide, Metformin. However, they are not optimum solution especially 
for developing country like Vietnam. They retain many side effects and relatively 
expensive. There is a need to investigate herbal drug based medicine, which has available 
resources, easy to use, cheap and less side effects.  
Classification of diabetes mellitus  
Type I diabetes: Insulin-dependent or childhood-onset, is characterized by a lack of 
insulin production.  
Type II diabetes: Non-insulin-dependent or maturity/adult-onset diabetes.  
Type III or Gestational diabetes: This type of diabetes first occurs during pregnancy.  
Secondary diabetes: Diabetes may develop as a consequence of other diseases or 
medication.  
Prevalence and incidence of diabetes mellitus  
Globally, the prevalence of diabetes, without type distinction, was estimated to be 4% in 
1995. According to WHO, it is estimated that 3% of the world’s population have diabetes 
and the prevalence is expected to double by the year 2025 to 6.3%. There will be a 42% 
increase from 51 to 72 million in the developed countries and 170% increase from 84 to 
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228 million, in the developing countries. Thus, by the year 2025, over 75% of all people 
with diabetes will be in the developing countries, as compared to 62% in 1995.  
Medicinal plants constitute an important natural wealth of a country. They play a 
significant role in providing primary health care services to the rural population. They 
serve as therapeutic agents as well as important raw materials for the manufacture of 
traditional medicines. Ethnopharmacology is the study of plants used in traditional 
medicine and is therefore heavily reliant on interactions between researchers and 
indigenous communities who passed on the traditional knowledge over generations. Whilst 
in the main, ethnopharmacology focuses on the presence or absence of evidence for 
specific therapeutic responses through the use of herbal remedies, the field also extends 
into phytochemistry where the aim is to identify the chemical constituent of the plant or 
plant extract that is responsible for the pharmacological activities inherent to a specific 
plant.  
In the last few years there has been an exponential growth in the field of herbal 
medicine and these drugs are gaining popularity both in developing and developed 
countries because of their natural origin and less side effects. Many traditional medicines in 
use are derived from medicinal plants, minerals and organic matter. WHO has listed 21,000 
plants, which are used for medicinal purposes around the world. Therefore, with the rising 
number of diseases lately, many researchers have evaluated the medicinal plants as 
alternative therapeutic agents. The effectiveness and safety of drugs derived from 
medicinal plants require scientific evaluation to establish the profiles of therapeutic 
effectiveness and toxicity of plant products. One example of such products is 
antihyperglycemic agents for use in the treatment of diabetes mellitus.  
 
Importance of medicinal plants and traditional medicines  
Medicinal plants, since time immemorial, have been used in virtually all cultures as 
a source of medicine. It has been estimated that about 80-85% of population both in 
developed and developing countries rely on traditional medicine for their primarily health 
care needs and it is assumed that a major part of traditional therapy involves the use of 
plant extracts or their active principles. Due to lack of organized health care systems in 
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developing countries like Ethiopia, people with chronic diseases like diabetes are among 
the worst suffers in their communities today. Hence, most of the populations still have 
limited access or no access, especially those in remote areas, to modern medicines. Instead 
they use traditional medicines for a range of diabetic complications.  
 
 
Fig 1. Main Symptoms of Diabetes 
Overview of the most significant symptoms of diabetes 
The classic symptoms of untreated diabetes are weight loss, polyuria (frequent 
urination), polydipsia (increased thirst), and polyphagia (increased hunger). Symptoms may 
develop rapidly (weeks or months) in type 1 diabetes, while they usually develop much 
more slowly and may be subtle or absent in type 2 diabetes. 
Several other signs and symptoms can mark the onset of diabetes, although they are not 
specific to the disease. In addition to the known ones above, they include blurry vision, 
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headache, fatigue, slow healing of cuts, and itchy skin. Prolonged high blood glucose can 
cause glucose absorption in the lens of the eye, which leads to changes in its shape, 
resulting in vision changes. A number of skin rashes that can occur in diabetes are 
collectively known as diabetic dermadromes. 
 
Fig 2. Fate of Type-II diabetes 
 People (usually with type 1 diabetes) may also experience episodes of diabetic 
ketoacidosis, a type of metabolic problems characterized by nausea, vomiting 
and abdominal pain, the smell of acetone on the breath, deep breathing known as Kussmaul 
breathing, and in severe cases a decreased level of consciousness.  
A rare but equally severe possibility is hyperosmolar nonketotic state, which is 
more common in type 2 diabetes and is mainly the result of dehydration. 
Complications 
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All forms of diabetes increase the risk of long-term complications. These typically 
develop after many years (10–20), but may be the first symptom in those who have 
otherwise not received a diagnosis before that time. 
             The major long-term complications relate to damage to blood vessels. Diabetes 
doubles the risk of cardiovascular disease and about 75% of deaths in diabetics are due to 
coronary artery disease. Other "macrovascular" diseases are stroke, and peripheral vascular 
disease. 
The primary microvascular complications of diabetes include damage to the eyes, 
kidneys, and nerves. Damage to the eyes, known as diabetic retinopathy, is caused by 
damage to the blood vessels in the retina of the eye, and can result in gradual vision loss 
and potentially blindness. Damage to the kidneys, known asdiabetic nephropathy, can lead 
to tissue scarring, urine protein loss, and eventually chronic kidney disease, sometimes 
requiring dialysis or kidney transplant. Damage to the nerves of the body, known 
as diabetic neuropathy, is the most common complication of diabetes. The symptoms can 
include numbness, tingling, pain, and altered pain sensation, which can lead to damage to 
the skin. Diabetes-related foot problems (such as diabetic foot ulcers) may occur, and can 
be difficult to treat, occasionally requiring amputation. Additionally, proximal diabetic 
neuropathy causes painful muscle wasting and weakness. 
There is a link between cognitive deficit and diabetes. Compared to those without 
diabetes, those with the disease have a 1.2 to 1.5-fold greater rate of decline in cognitive 
function. 
Diagnosis 
Diabetes mellitus is characterized by recurrent or persistent hyperglycemia, and is 
diagnosed by demonstrating any one of the following:  
 Fasting plasma glucose level ≥ 7.0 mmol/l (126 mg/dl) 
 Plasma glucose ≥ 11.1 mmol/l (200 mg/dl) two hours after a 75 g oral glucose load 
as in a glucose tolerance test 
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 Symptoms of hyperglycemia and casual plasma glucose ≥ 11.1 mmol/l          
    (200 mg/dl) 
 Glycated hemoglobin (Hb A1C) ≥ 6.5%. 
A positive result, in the absence of unequivocal hyperglycemia, should be confirmed by a 
repeat of any of the above methods on a different day. It is preferable to measure a fasting 
glucose level because of the ease of measurement and the considerable time commitment 
of formal glucose tolerance testing, which takes two hours to complete and offers no 
prognostic advantage over the fasting test. According to the current definition, two fasting 
glucose measurements above 126 mg/dl (7.0 mmol/l) is considered diagnostic for diabetes 
mellitus. 
Per the World Health Organization people with fasting glucose levels from 6.1 to 
6.9 mmol/l (110 to 125 mg/dl) are considered to have impaired fasting glucose. People with 
plasma glucose at or above 7.8 mmol/l (140 mg/dl), but not over 11.1 mmol/l (200 mg/dl), 
two hours after a 75 g oral glucose load are considered to haveimpaired glucose tolerance. 
Of these two prediabetic states, the latter in particular is a major risk factor for progression 
to full-blown diabetes mellitus, as well as cardiovascular disease. The American Diabetes 
Association since 2003 uses a slightly different range for impaired fasting glucose of 5.6 to 
6.9 mmol/l (100 to 125 mg/dl).  
Glycated hemoglobin is better than fasting glucose for determining risks of 
cardiovascular disease and death from any cause.  
The rare disease diabetes insipidus has similar symptoms to diabetes mellitus, but 
without disturbances in the sugar metabolism (insipidus means "without taste" in Latin) 
and does not involve the same disease mechanisms. 
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Fig 3. Oral antidiabetic agents site of action 
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WHO DIABETES DETAILS 
Condition 2 hour 
glucose     
Fasting glucose HbA1c                                                                                               
Unit mmol/l(mg/dl
) 
mmol/l(mg/dl) % 
Normal <7.8 (<140) <6.1 (<110) <6.0 
Impaired fasting glycaemia  <7.8 (<140) ≥ 6.1(≥110) & 
<7.0(<126) 
6.0–6.4 
Impaired glucose tolerance  ≥7.8 (≥140) <7.0 (<126) 6.0–6.4 
Diabetes mellitus ≥11.1 (≥200) ≥7.0 (≥126) ≥6.5 
Table 1. WHO diabetes Information chart 
Prevention and Treatment 
There is no known preventive measure for type 1 diabetes. Type 2  diabetes can 
often be prevented by a person being a normal body weight, physical exercise, and 
following a healthy diet. Dietary changes known to be effective in helping to prevent 
diabetes include a diet rich in whole grains and fiber, and choosing good fats, such 
as polyunsaturated fats found in nuts, vegetable oils, and fish. Limiting sugary beverages 
and eating less red meat and other sources of saturated fat can also help in the prevention of 
diabetes.  Active smoking is also associated with an increased risk of diabetes, so smoking 
cessation can be an important preventive measure as well.  
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Diabetes mellitus is a chronic disease, for which there is no known cure except in very 
specific situations. Management concentrates on keeping blood sugar levels as close to 
normal ("euglycemia") as possible, without causing hypoglycemia. This can usually be 
accomplished with diet, exercise, and use of appropriate medications (insulin in the case of 
type 1 diabetes; oral medications, as well as possibly insulin, in type 2 diabetes). 
Learning about the disease and actively participating in the treatment is vital for people 
with diabetes, since the complications of diabetes are far less common and less severe in 
people who have well-managed blood sugar levels. The goal of treatment is an HbA1C 
level of 6.5%, but should not be lower than that, and may be set higher.  Attention is also 
paid to other health problems that may accelerate the deleterious effects of diabetes. These 
include smoking, elevated cholesterollevels, obesity, high blood pressure, and lack of 
regular exercise. Specialised footwear is widely used to reduce the risk of ulceration, or re-
ulceration, in at-risk diabetic feet. 
Lifestyle: 
People with diabetes can benefit from education about the disease and treatment, 
good nutrition to achieve a normal body weight, and sensible exercise, with the goal of 
keeping both short-term and long-term blood glucose levels within acceptable bounds. In 
addition, given the associated higher risks of cardiovascular disease, lifestyle modifications 
are recommended to control blood pressure.  
Medications: 
Metformin is generally recommended as a first line treatment for type 2 diabetes, as 
there is good evidence that it decreases mortality. Routine use of aspirin, however, has not 
been found to improve outcomes in uncomplicated diabetes. Angiotensin converting 
enzyme inhibitors (ACEIs) improve outcomes in those with DM while the similar 
medications angiotensin receptor blockers (ARBs) do not.  
Type 1 diabetes is typically treated with a combinations of regular and NPH insulin, or 
synthetic insulin analogs. When insulin is used in type 2 diabetes, a long-acting 
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formulation is usually added initially, while continuing oral medications.  Doses of insulin 
are then increased to effect.  
In those with diabetes some recommend blood pressure levels below 
120/80 mmHg;  however, evidence only supports less than or equal to somewhere between 
140/90 mmHg to 160/100 mmHg.  
      
 Table 2. Oral antihyperglycemics 
Pancreatic transplantation 
A pancreas transplant is occasionally considered for people with type 1 diabetes 
who have severe complications of their disease, including disease requiring kidney 
transplantation. 
Support: 
In countries using a general practitioner system, such as the United Kingdom, care 
may take place mainly outside hospitals, with hospital-based specialist care used only in 
case of complications, difficult blood sugar control, or research projects. In other 
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circumstances, general practitioners and specialists share care in a team approach. 
Home telehealth support can be an effective management techni 
 Diets And Exercise Treatment                                                                                                   
Making healthy food choices is very important to help keep your blood glucose level under 
control. People with diabetes don't need to buy or prepare special foods. The foods that are 
best for someone with diabetes are excellent choices for everyone: foods that are low in fat, 
salt, and sugar, and high in fiber, such as beans, fruits, vegetables, and whole grains. These 
foods help you reach and stay at a weight that's good for your body. Regular physical 
activity is important for people with diabetes. Being physically active has been shown to 
improve blood glucose levels in older people whose levels are high. Exercise is especially 
good for people with diabetes because it helps control weight, helps insulin work better to 
lower blood glucose, is good for your heart and lungs, gives you more energy,  Regular 
physical activity improves insulin resistance and lipid profile (reduction in triglyceride and 
increase in high-density lipoprotein (HDL)) and lowers blood pressure (although blood 
pressure will rise during exercise),the metabolic benefits in type 2 diabetes are lost within 
3-10 days of stopping regular exercise, physical activity also protects against the 
development of type 2 diabetes 
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Fig 4. Classification of Sulphonyl Ureas 
 
A1C Test 
The A1C test is used to detect type 2 diabetes and prediabetes but is not 
recommended for diagnosis of type 1 diabetes or gestational diabetes. The A1C test is a 
blood test that reflects the average of a person’s blood glucose levels over the past 3 
months and does not show daily fluctuations. The A1C test is more convenient for patients 
than the traditional glucose tests because it does not require fasting and can be performed at 
any time of the day.The A1C test result are reported as a percentage. The higher the 
percentage, the higher a person’s blood glucose levels have been. A normal A1C level is 
below 5.7 percent. An A1C of 5.7 to 6.4 percent indicates prediabetes. People diagnosed 
with prediabetes may be retested in 1 year. People with an A1C below 5.7 percent may still  
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be at risk for diabetes, depending on the presence of other characteristics that put them at 
risk, also known as risk factors. People with an A1C above 6.0 percent should be 
considered at very high risk of developing diabetes. A level of 6.5 percent or above means 
a person has diabetes. 
Herbal drugs used in the treatment of Diabetes Mellitus   
Allopathic medicines are very costly. In contrast, herbal medicines are very cheap. This 
cost effectiveness makes them all the more alluring. Herbal medicines can be brought 
without prescription and they are available in all most all health stores. Some herbs can 
even be grown at home. For certain ailments, herbal medicines are considered to be more 
effective than allopathic medicines. 
Herbal medicines do not have any side effects, as they are free from chemicals. They are 
also milder than allopathic medicines. The natural detoxification process of the body is 
effectively enhanced by herbal medicines. They can be used to cleanse the colon, improve 
digestion and food absorption. Herbal medicines are also very good in boosting the immune 
system. 
Herbal medicines are very effective in curing various digestive disorders like 
colitis, indigestion, peptic ulcers, and irregular bowel movements. These types of medicines 
are best for people who are allergic to various types of drugs. Herbal medicines are also 
effective in boosting the mental health. Most of the ailments related to blood circulation like 
high blood pressure, varicose ulcers, and many others can be controlled through herbal 
medicine. Some herbal medicines are very good in reducing the cholesterol level in the 
blood stream. They are also used to treat coronary artery diseases. Herbal medicine can be 
used to reduce weight by regulating appetite. 
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S.No Botanical name Family 
1.  Afzelia africana  Fabaceae  
2.  Amaranthus caudatus  Amaranthaceae  
3.  Andrographis lineata  Acanthaceae  
4.  Annona squamosa  Annonaceae  
5.  Artocarpus heterophyllus  Moraceae  
6.  Boerhaavia diffusa  Nyctaginaceae  
7.  Berberis vulgaris  Berberidaceae  
8.  Brassica juncea  Brassicaceae  
9.  Caesalpinia bonduc  Fabaceae  
10.  Caesalpinia digyna  Caesalpiniaceae  
11.  Cassia glauca  Caesalpiniaceae  
12.  Cassia siamea  Fabaceae  
13.  Cleome aspera  Capparaceae  
14.  Clitoria ternatea  Fabaceae  
15.  Coccinia indica  Cucurbitaceae  
16.  Decalepis root  Asclepiadaceae  
17.  Diospyros peregrina  Ebenaceae  
18.  Dodonaea viscosa  Sapindaceae  
19.  Enicostemma littorale  Gentianaceae  
20.  Eucalyptus globules  Myrtaceae  
21.  Holarrhena antidysenterica  Apocynaceae  
22.  Hybanthus enneaspermus  Violaceae  
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23.  Hypericum perforatum  Hypericaceae  
24.  Lawsonia inermis  Lythraceae  
25.  Leonotis leonurus  Lamiaceae  
26.  Litsea coreana  Lauraceae  
27.  Madhuca longifolia  Sapotaceae  
28.  Morus rubra  Moraceae  
29.  Nyctanthes arbor-tristis  Oleaceae  
30.  Olea europaea  Oleaceae  
31.  Otostegia persica  Lamiaceae  
32.  Phlomis persica  Lamiaceae  
33.  Punica granatum  Lythraceae  
34.  Rhus coriaria  Anacardiaceae  
35.  Rosa canina  Rosaceae  
36.  Salmalia malabarica  Bombacaceae  
37.  Sansevieria roxburghiana  Ruscaceae  
38.  Swietenia macrophylla  Meliaceae  
39.  Symplocos cochinchinensis  Symplocaceae  
40.  Syzygium cumini  Myrtaceae  
41.  Tapinanthus bangwensis  Loranthaceae  
42.  Terminalia bellerica  Combretaceae  
43.  Terminalia superba  Combretaceae  
     44. Thespesia populnea  Malvaceae  
Table 3. List of pharmacologically tested anti-diabetic plant materials in steptozotocin 
induced diabetic animal model 
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Researchers are wanting to perform antidiabetic considered on ethanolic leaves 
concentrate of Averrhoa carambola having a place with the family Rubiaceae3,5. it was 
acknowledged from the different reports that Averrhoa carambola have potential organic 
exercises, for example, anticancer, hepatoprotective, calming, antifertility, antiamoebic, 
antinociptive etc. from its different parts. moreover, this plant have additionally utilized as 
a part of curing different afflictions, for example, ailment, stomach ache, cerebral pain, 
cool/hack, toothache, fever, agony and swelling, bacterial disease, urinary issues, 
conjunctivitis, unnatural birth cycle etc. Keeping the perspective of the previously 
mentioned restorative significance of this plant as my present examination has planned as 
"Assessment of antidiabetic action of alcoholic concentrates of Averrhoa carambola leaves 
on streptozotocin induced diabetic rats.6,7,8 
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2. LITERATURE REVIEW 
1. Aktiviti et al 2014., evaluated the Antioxidant Activity (AA), Total Flavonoid 
Content (TFC), and Total Phenolic Content (TPC) of Oxalidaceae fruit extracts. Two types 
of Averrhoa carambola L. and two types of bilimbi fruits were used in this study. Bilimbi 
fruits selected were Averrhoa bilimbi L. and Averrhoa bilimbi cv. while Averrhoa 
carambola L. selected were Averrhoa carambola L. (honey type) and another type of 
Averrhoa carambola L. which is known as tart type. The maturity stage for both Averrhoa 
carambola L. fruits (honey and tart type) were selected at commercial maturity stages 
which were stage 3 and stage 4. Antioxidant estimation of oxalidaceae fruit extracts were 
evaluated by using Total Flavonoid Content (TFC) and Total Phenolic Content (TPC), 
while antioxidant activity were evaluated using scavenging of 2,2-diphenyl-1-
picrylhydrazyl radical (DPPH), β- carotene Bleaching (BCB) and Ferric Reducing 
Antioxidant Power (FRAP) assays. Phytochemical screening of alkaloids, flavonoids, 
terpenoids, steroids, tannins and saponins were also performed on all samples. Averrhoa 
carambola L. indicated positive results for all phytochemical screening conducted and 
similar results were observed from bilimbi fruits, except for alkaloids. Averrhoa carambola 
L. (tart type) of stage 4 possessed higher TPC and TFC followed by Averrhoa carambola L. 
(honey type) of stage 4. Averrhoa carambola L. (tart type) of stage 4 also exhibited high 
scavenging effect (74 %) as determined by DPPH assay with the value of EC50 72.36 
mg/ml while Averrhoa carambola L. (honey type) of stage 3 showed significantly lower 
percentage of scavenging effect. The results also demonstrated that FRAP values of 
Averrhoa carambola L. (honey type) of stage 4 and Averrhoa carambola L. (tart type) of 
stage 4 were higher than other samples (5.1023 mmol TE/g and 5.0759 mmol TE/g) and 
similar trends were observed for β-carotene Bleaching (BCB) assay, where Averrhoa 
carambola L. (honey type) of stage 4 had the highest value. There were strong positive 
correlations between antioxidant activity assays and TPC or TFC, hence indicating that the 
four types of Oxalidaceae fruits used in this study have the potential as natural antioxidant8. 
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2. Yin Sze Lim et al., 2013. and Shi Ting Lee Illustrated underutilised tropical fruit 
that could serves as an alternative food sources to the world. The current study was, 
therefore, undertaken to investigate the functional potentials of green and ripe star fruits by 
determining its antioxidant contents and capacities. The antioxidant capacities of star fruit 
were increased significantly with ripening, except for the total ascorbic acid content. The 
ripe star fruit peel contained higher total polyphenol (98.19 g TAE/100 g FW), total 
flavanol (33.31 g CAE/100 g FW) and ascorbic acid contents (1.56 g AAE/100 g FW) than 
green star fruit peel. Ripe star fruit peel also demonstrated stronger FRAP (1.41 M 
FEA/100 g FW) and DPPH (75 % inhibition) values than green star fruit peel. The 
antioxidant capacities of peel were greater than pulp. On the basis of results obtained, the 
ripe star fruit is a potential source of natural antioxidants owing to its significant 
antioxidant activities. 
3. Suman das et al .,2012.Consumption of diets rich in fruits, vegetables and 
derived food products can bring substantial health benefits. Research interest thus has 
increased in natural antioxidants and antimicrobials present in herbs, fruits or vegetables. 
Underutilized tropical fruits of India provide limitless opportunities for screening of novel 
drugs. Present study was aimed to understand the antimicrobial and antioxidant activities of 
tropical fruits Averrhoa carambola Linn. (starfruit) and Zizyphus mauritiana Lam. (jujube) 
fruits. The edible parts of the fruits were analyzed for different phytochemicals and 
phenolics, flavonoids, alkaloids and glycosides were found in all ripe and green starfruits 
or jujubes. Green fruits of Averrhoa carambola showed better antimicrobial activities in 
comparison with ripe varieties. Widest inhibition zones (14-15 mm DIZ) were seen in cases 
of extracts of ripe Zizyphus mauritiana against Escherichia coli and Staphylococcus aureus. 
Common antioxidants like Phenolics, flavonoids and ascorbate were measured. Extracts of 
ripe fruits contain higher amounts of flavonoids and ascorbate. Bers contain higher amount 
of ascorbate than starfruits. Ripe jujube or Zizyphus mauritiana extract showed strongest 
free radical scavenging or antioxidant activity among the tested. 
3.Thomas R et al., 2016. Explained Pork nuggets with 'very good' acceptability was 
processed by incorporating kordoi (Averrhoa carambola) fruit juice and bamboo (Bambusa 
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polymorpha) shoot extract, and their physical, chemical, microbiological and sensorial 
characteristics were evaluated during 35 days storage under refrigeration. Addition of 
kordoi fruit juice (4%) and bamboo shoot extract (6%) had a significant effect on the pH, 
moisture, protein, fat, fiber, instrumental color values and texture profiles of nuggets. 
Nuggets with juice and extract had significantly lower TBARS values towards the end of 
the storage period compared to the control. Microbial and sensory qualities of nuggets were 
significantly improved by the addition of juice and extract. Incorporation of juice and 
extract at 4% and 6% levels, respectively, increased the storage life of pork nuggets by at 
least two weeks, i.e. from 21 days to 35 days at 4 ± 1 °C compared to the control. 
4.Rupal A et al., 2014. Explained the Consumption of fluoride leads to several 
physiological disturbances in carbohydrate, lipid and antioxidant metabolisms. Averrhoa 
carambola L. fruit (Star fruit) is a commonly consumed fruit in tropical countries and is an 
ingredient in folklore medicines. As the fruits have high polyphenolic and antioxidant 
contents, the present study was undertaken to investigate the potential of star fruit as a 
dietary supplement in attenuating the fluoride induced hyperglycemia, 
hypercholesterolemia and oxidative stress in laboratory rats. A four-week exposure to 
fluoride caused sustained hyperglycemia, hyperlipidemia and oxidative stress and, when 
the diet was supplemented with star fruit powder, carbohydrate, lipid and antioxidant 
profiles were restored significantly. It is surmised that the antihyperglycemic, 
antihypercholesterolemic and antioxidant activities of star fruit in fluoride exposed rats 
could be due to the presence of polyphenols, flavonoids, saponins, phytosterols, ascorbic 
acid and fibers in the fruit, which are all well known regulators of carbohydrate, lipid and 
antioxidant metabolisms. These findings suggest that star fruit can be used as a dietary 
supplement in fluoride endemic regions to contain fluoride induced hyperglycemia, 
hyperlipidemia and oxidative stress. 
5.Phukan S et al., 2016. Evaluation of the antimicrobial, analgesic and antioxidant 
activity of ethanolic extract of the leaves of Averrhoa Carambola.  To test the 
antimicrobial activity the organisms used were S. aureus, Klebsiella sp, E. coli and P. 
aeruginosa, C. albicans. Zone of inhibitions produced by sensitive organisms were 
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demarcated by a circular area of clearing around plant extract impregnated discs and were 
compared with zone of inhibitions of positive controls. Analgesic activity was tested by 
two methods: acetic acid induced writhing test and Eddy’s hot plate mediated pain reaction. 
The animals were divided into 5 groups: Group I (Normal control), Group II (Standard 
drug), Group III, IV, V (Ethanolic extract of A.carrambola in the doses of 100, 200 and 
400mg/kg respectively). To test the antioxidant activity, the mice were divided into 6 
groups containing. Paracetamol in the dose of 250mg/kg p.o was administered to all the 
groups except the first group, which was taken as the normal control, for 10 days to induce 
oxidative stress. Silymarin in the dose of 25mg/kg p.o was given to the third group as a 
standard antioxidant. Group IV, V and VI received extract in the dose of 200mg/kg, 
400mg/kg and 800mg/kg respectively.  Mean ± SEM values were calculated for each 
group. The data were analyzed using ANOVA and post analysis was done by Dunnett’s 
test. Results were found to be significant (p<.05).  The results of the present study revealed 
the antimicrobial, analgesic and antioxidant activity of the leaf ethanolic extract 
of A.carrambola. 
6.Sindhu Nettem et al., 2013. Detailed Averrhoa carambola of family Oxalidaceae 
is commonly known as star fruit, carambola and in local name Kamrakh 
(hindi),Ambanamkaya (telugu). Various parts of tree has been used in traditional folkloric 
medicine. The present study was concentrated on the in-vitro antioxidant methods like 
DPPH free radical, nitric oxide radical, hydrogen peroxide radical scavenging and reducing 
power assays. The ethanolic extract of Averrhoa carambola stem was subjected to the 
above methods. The results of anti oxidant activity revealed that, the ethanolic extract 
shows good IC50 values. The results were compared with the standard ascorbic acid. The 
plant contains flavonoids, alkaloids, saponins and tannins. These active constituents alone 
or in combination may be responsible for the observed antioxidant activity. 
7.Edilene et al., 2008. Studied the effect of the oral treatment (20 mg/kg x day) 
with the hydroalcoholic extract of leaves of Averrhoa carambola L. (HELAC) on fasting 
glycaemia (15 h) was examined. For this purpose, rats that received vehicle (Control 
group) or HELAC (HELAC group) during 15 days were compared. HELAC group showed 
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lower fasting glycemia (p<0.05). In contrast, livers from HELAC group showed higher 
(p<0.05) glucose production from L-alanine (5 mM). This effect was mediated, at least part 
of it, by an activation of the catabolism of L-alanine inferred by the increased hepatic urea 
(p<0.05) and L-lactate (p<0.05) production. Differently of L-alanine, the glucose 
production from L-glutamine (5 mM), L-lactate (2 mM) and glycerol (2 mM) was similar 
(Control group vs. HELAC group). In addition, the HELAC treatment did not change the 
glucose uptake in soleus muscles, inferred by the incorporation of [14C]-glucose to 
glycogen (glycogen synthesis) and [14C]-lactate production. Thus, we can conclude that the 
reduction of fasting glycemia promoted by the treatment with HELAC was not mediated by 
an inhibition of hepatic gluconeogenesis and/or an increased glucose uptake by muscles. 
8.Shejuty Shahreen et al., 2011. Explained and studied Averrhoa carambola L. 
(Oxalidaceae), Ficus hispida L.f. (Moraceae), and Syzygium samarangense(Blume) Merr. 
& L.M. Perry (Myrtaceae) are three common plants in Bangladesh, the fruits of which are 
edible. The leaves and fruits of A. carambola and F. hispida are used by folk medicinal 
practitioners for treatment of diabetes, while the leaves of S. samarangense are used for 
treatment of cold, itches, and waist pain. Since scientific studies are absent on the 
antihyperglycemic effects of the leaves of the three plants, it was the objective of the 
present study to evaluate the antihyperglycemic potential of methanolic extract of leaves of 
the plants in oral glucose tolerance tests carried out with glucose-loaded mice. The extracts 
at different doses were administered one hour prior to glucose administration and blood 
glucose level was measured after two hours of glucose administration (p.o.) using glucose 
oxidase method. Significant oral hypoglycaemic activity was found with the extracts of 
leaves of all three plants tested. The fall in serum glucose levels were dose-dependent for 
every individual plant, being highest at the highest dose tested of 400 mg extract per kg 
body weight. At this dose, the extracts of A. carambola, F. hispida, and S. 
samarangense caused, respectively, 34.1, 22.7, and 59.3% reductions in serum glucose 
levels when compared to control animals. The standard antihyperglycemic drug, 
glibenclamide, caused a 57.3% reduction in serum glucose levels versus control. Among 
the three plants evaluated, the methanolic extract of leaves of S. samarangense proved to 
be the most potent in demonstrating antihyperglycemic effects. The result validates the folk 
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medicinal uses of A. carambola and F. hispida in the treatment of diabetes, and indicates 
that the leaves of S. samarangense can also possibly be used for amelioration of diabetes-
induced hyperglycemia. 
9.Dasgupta et al., 2013. Studied the positive effects of plants on human physiology 
have enlarged the range of application of medicinal plants. From the centuries, herbal 
medicines have been used to treat various diseases and now they had become an item of 
global importance, with both medicinal and economic implications. Selecting the right 
scientific and systematic approach to biological evaluation of plant products, based on their 
use in traditional medicine is the key to ideal development of new drugs from plants. One 
such plant is Averrhoa carambola (Oxalidaceae), traditionally known as ‘kamrakh’ and 
commonly known as star fruit because of its peculiar shape It has widely been used in 
Ayurveda, preparations of its fruit and leaves are used to pacify impaired kapha, pitta, skin 
diseases, pruritis, worm infestations, diarrhea, vomiting, hemorrhoids, intermittent fever, 
over-perspiration and general debility. It is also used in traditional medicines in countries 
like India, China, Phillipines, Brazil for various ailments. Although review articles on this 
plant are already published, but the present attempt is to review and compile all the updated 
information on botany, phytochemical and pharmacological properties, drug interaction, 
contraindication and toxicity studies of Averrhoa carambola. These results are very 
encouraging and indicate that this plant should be studied more extensively to confirm the 
reproducibility of these results and also to reveal other potential therapeutic effects, along 
with some “leads” with possible isolation of active biomoieties and their mechanism of 
action. 
10.Sultan et al .,2013.  Explained Averrhoa carambola L. (Oxalidaceae), commonly 
known as star fruit bears a great significance in traditional medicine. Traditionally, A. 
carambola was used in ailments such as arthralgia, chronic headache, boils and pyodermas, 
colds, cough, epistaxis, spermatorrhea, fever, food poisoning, gastroenteritis, malaria, 
malarial splenomegaly, oliguria, postpartum edema, sore throat, subcalorism and traumatic 
injury. Pharmacological investigations on A. carambola have demonstrated anti-
inflammatory, antimicrobial, antifungal, antitumor and anti-ulcer activities. In addition, the 
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plant possesses hypocholesterolemic, hypoglycemic, hypotensive, nephrotoxic, neurotoxic, 
negative inotropic and chronotropic effects. Phytochemical investigations have shown the 
presence of saponins, tannins, alkaloids and flavonoids. This review is an effort to update 
the pharmacological activities and clinical studies on A. carambola. 
11.Shareen et al., 2012. Averrhoa carambola L. (Oxalidaceae), Ficus hispida L.f. 
(Moraceae), and Syzygium samarangense (Blume) Merr. & L.M. Perry (Myrtaceae) are 
three common plants in Bangladesh, the fruits of which are edible. The leaves and fruits 
of A. carambola and F. hispida are used by folk medicinal practitioners for treatment of 
diabetes, while the leaves of S. samarangense are used for treatment of cold, itches, and 
waist pain. Since scientific studies are absent on the antihyperglycemic effects of the leaves 
of the three plants, it was the objective of the present study to evaluate the 
antihyperglycemic potential of methanolic extract of leaves of the plants in oral glucose 
tolerance tests carried out with glucose-loaded mice. The extracts at different doses were 
administered one hour prior to glucose administration and blood glucose level was 
measured after two hours of glucose administration (p.o.) using glucose oxidase method. 
Significant oral hypoglycemic activity was found with the extracts of leaves of all three 
plants tested. The fall in serum glucose levels were dose-dependent for every individual 
plant, being highest at the highest dose tested of 400 mg extract per kg body weight. At this 
dose, the extracts of A. carambola, F. hispida, and S. samarangense caused, respectively, 
34.1, 22.7, and 59.3% reductions in serum glucose levels when compared to control 
animals. The standard antihyperglycemic drug, glibenclamide, caused a 57.3% reduction in 
serum glucose levels versus control. Among the three plants evaluated, the methanolic 
extract of leaves of S. samarangense proved to be the most potent in demonstrating 
antihyperglycemic effects. The result validates the folk medicinal uses of A. 
carambola and F. hispida in the treatment of diabetes, and indicates that the leaves of S. 
samarangense can also possibly be used for amelioration of diabetes-induced 
hyperglycemia. 
12.Daniela et al., 2011. Briefed Inflammatory skin disorders, such as psoriasis and 
atopic dermatitis, are very common in the population; however, the treatments currently 
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available are not well tolerated and are often ineffective. Averrhoa carambola L. 
(Oxalidaceae) is an Asian tree that has been used in traditional folk medicine in the 
treatment of several skin disorders. The present study evaluates the topical anti-
inflammatory effects of the crude ethanolic extract of A. carambola leaves, its hexane, 
ethyl acetate, and butanol fractions and two isolated flavonoids on skin inflammation. Anti-
inflammatory activity was measured using a croton oil-induced ear edema model of 
inflammation in mice. Topically applied ethanolic extract reduced edema in a dose-
dependent manner, resulting in a maximum inhibition of 73 ± 3% and an ID50 value of 
0.05 (range: 0.02–0.13) mg/ear. Myeloperoxidase (MPO) activity was also inhibited by the 
extract, resulting in a maximum inhibition of 60 ± 6% (0.6 mg/ear). All of the fractions 
tested caused inhibition of edema formation and of MPO activity. Treatment with the ethyl 
acetate fraction was the most effective, resulting in inhibition levels of 75 ± 5 and 54 ± 8% 
for edema formation and MPO activity, respectively. However, treatment of mice with 
isolated compounds [apigenin-6-C-β-l-fucopyranoside and apigenin-6-C-(2__-O-α-l-
rhamnopyranosyl)-β-l-fucopyranoside] did not yield successful results. Apigenin-6-C-(2 -
O-α-l-rhamnopyranosyl)-β-l-fucopyranoside caused only a mild reduction in edema 
formation (28 ± 11%). Taken together, these preliminary results support the popular use of 
A. carambola as an anti-inflammatory agent and open up new possibilities for its use in 
skin disorders. 
13.Sandipan Mazumder et al 2013., detailed Different parts of the plant Averrhoa 
carambola L. is used for the treatment of various disease/disorder (s) by ethnic 
communities from North Maharashtra and Sonowal Kachari tribes of Dibrugarh, Assam. 
Still no scientific study is available about the hepatoprotective effect of the leaf of this 
plant. Present investigation aims to illustrate the hepatoprotective and antioxidant profile of 
leaves of Averrhoa carambola on carbon tetrachloride induced hepatic damage in mice. To 
achieve the objective, extracts were subjected to phytochemical screening. The leaf extract 
was then tested for its oral toxicity which was followed by evaluation of hepatoprotective 
and antioxidant activity at a dose level of 100mg/kg bw, 200mg/kg bw and 400mg/kg bw 
orally. Moreover, the hepatoprotective effect was further sustained by validating the leaf 
extract against different pharmacological parameters. Leaf extract of A.carambola possess 
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phytoconstituents like alkaloids, tannins, reducing sugar and flavonoids. The extract did not 
any show any sign of toxicity. The pre-treatment of extract had significantly controlled the 
levels of serum biochemical and antioxidant enzymes. Finally the grades of 
hepatoprotectivity were further confirmed while experimenting against other parameters. 
Finally it can be concluded that the study demonstrates hepatoprotective and antioxidant 
activity of leaf of Averrhoa carambola and thus supports its usage in traditional medicine. 
14.Tanzirr et al., 2017 . Phytochemical analysis of the ethanolic leaf extract of 
Averrhoa carambola Linn. Indicated the presence of carbohydrate, glycosides, steroid, 
saponins, flavonoids, gum, tannins and the absence of reducing sugars. On acetic acid 
induced analgesic test, the plant extract exhibited a significant writhing reflex inhibition 
by 11.12% and 40.28% (p 0.01) at the dose of 250 mg/kg and 500 mg/kg body-weight 
respectively while the standard drug diclofenac sodium inhibition was found to be 
69.45% at a dose of 25 mg/kg body weight. The plant extract showed moderate level of 
antimicrobial activity against Streptococcus agalactiae, Streptococcus pyogenes, Shigella 
dysenteriae, Pseudomonas spp., Staphylococcus saprophyticus when Kanamycine was 
applied at the dose of 30 µg/disc. On qualitative in vitro antioxidant assay (2, 2-
diphenyl-1-picryl hydrazyl (DPPH) method), the ethanolic leaf extract was found to have 
potent antioxidant compounds. In the castor oil-induced diarrhoeal mice, the plant 
extract significantly reduced the number of stools by 25% and 31.25%.  
15.Ritu singh et al., 2014. Liver cancer remains one of the severe lethal 
malignancies worldwide and hepatocellular carcinoma (HCC) is the most common form. 
The current study was designed to evaluate the prophylactic role of the fruit of Averrhoa 
carambola (star fruit or Kamrak) on diethylnitrosamine- (DENA-) induced 
(15 mg/kg b.wt.; single i.p. injection) and CCl4-promoted (1.6 g/kg b.wt. in corn oil 
thrice a week for 24 weeks) liver cancer in Swiss albino mice. Administration of ACE 
was made orally at a dose of 25 mg/kg b.wt/day for 5 consecutive days and it was 
withdrawn 48 hrs before the first administration of DENA (preinitiational stage). 
CCl4 was given after 2 weeks of DENA administration. A cent percent tumor incidence 
was noted in carcinogen treated animals while ACE administration resulted in a 
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considerable reduction in tumor incidence, tumor yield, and tumor burden. Further, ACE 
treatment brings out a significant reduction in lipid peroxidation () along with an 
elevation in the activities of enzymatic antioxidants (superoxide dismutase, , and 
catalase, ), nonenzymatic antioxidant (reduced glutathione, ), and total proteins () when 
compared to the carcinogen treated control. These results demonstrate that ACE prevents 
the DENA/CCl4 induced adverse physical and biochemical alterations during hepatic 
carcinogenesis in mice. This study suggests the prophylactic role of Averrhoa 
carambola against hepatocellular carcinoma in mice; therefore, it could be employed for 
the further screening as a good chemopreventive natural supplement against cancer. 
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PLANT PROFILE 
Averrhoa carambola  
Star Fruit 
 Classification of Averrhoa carambola 
 Scientific Name: Averrhoa carambola  
Kingdom Plantae – Plants 
 Subkingdom Tracheobionta – Vascular plants 
 Superdivision Spermatophyta – Seed plants 
 Division Magnoliophyta – Flowering plants 
 Class Magnoliopsida – Dicotyledons  
Subclass Rosidae Order Geraniales 
 Family Oxalidaceae – Wood-Sorrel 
 family Genus Averrhoa Adans. – averrhoa Species Averrhoa carambola L. – carambola 
 Nomenclature, The carambola is known under different names in different countries. It 
should not be confused with the closely related bilimbi, with which it shares some common 
names9,10,11.  
 Bengali – kamranga 
 Assamese - kordoi  
 Marathi – karambal 
Telugu - ambanamkaya  
English - carambola, starfruit 
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Filipino - balimbing, saranate 
Hindi – kamrakh 
 Gujarati – kamrakh 
Malayalam – chathurapuli 
Tamil - thambaratham  
Indonesian – belimbing 
Malay – belimbing 
Sylheti – khafrenga 
Sinhala – Kamaranga 
Vietnamese - khế 
 
Figure 5. Leaves of Averrhoa carambola[ 
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Figure 6. Fruits of Averrhoa carambola 
 
 
Figure 7. Fruits and stems of Averrhoa carambola 
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3.AIM AND OBJECTIVE 
            Reason for choosing diabetes mellitus that few medications in clinical practice for 
the treatment, a hefty portion of these oral hostile to diabetic segment have been accounted 
for to demonstrate genuine antagonistic side effects. It is obvious that because of the 
reactions of the presently utilized medications, there is a requirement for a strong 
medication with negligible unfavorable impacts, which can be taken for long time. Plant 
materials which are being utilized as customary pharmaceutical for the treatment of diabetes 
are viewed as one of the great barriers for another medication or a prompt make another 
medication. All through the world numerous conventional plant medicines for diabetes 
exists. In any case, few have gotten logical or therapeutic investigation and the WHO has 
prescribed that customary plant medications for diabetes warrant promote assessment and 
logical approval. Presently I have under taken the investigation of "Assessment of 
antidiabetic of alcoholic, petroleum ether and ethyl acetate concentrates of Averrhoa 
carambola leaves on Streptozotocin induced diabetic rats. To meet this aim we framed 
following objectives.  
          
          OBJECTIVES 
1. To Extract the Averrhoa carambola using different solvent by Mantox Hapter 
2. To Study the prelimmery phyto chemical screening of Averrhoe carambola 
3. To Evaluate the In vitro Anti diabetic study of Averrhoe carambola 
4. To Evaluate the In vivo Anti diabetic study of Averrhoe carambol  
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4.PLAN OF THE WORK 
 
 
Authentication of the  Plant 
 
 
 
 
 
 
Extensive Literature survey of the plant 
 
Extracting the Averrhoa Carambola Leaves 
Phytochemical Screening of the selected Component 
 
 
In Vitro anti diabetic activity 
In Vivo anti diabetic activity 
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5. MATERIALS AND METHODS 
A) Plant collection and authentification 
The leaves of Averrhoa carambola were collected from Anantgiri forest, 
Hyderabad  
     B)    Preparation of  coarse powder and Extraction technique 
The leaves were shade dried at room temperature for 10 days. Then these were milled into 
powder by mechanical grinder. This powder was sequentially extracted to their increasing 
polarity with Petroleum ether, Ethyl acetate, Ethanol respectively. About 500gm of 
powdered leaf was uniformly packed into a thimble in a soxhlet apparatus and extracted 
with 1000ml Petroleum ether, Ethyl acetate and Ethanol, respectively. Constant heat was 
provided by Mantox heater for recycling of the solvent. The process of extraction continues 
for 1-2 hours for each solvent. The excess solvent was evaporated and the dried extracts 
were kept in refrigerator at 4ºC for their future use in phytochemical analysis and 
pharmacological screenings. 
     D) Preliminary phytochemical screening of ethanolic leaf extracts of Averrhoa 
carambola   
The ethanolic leaf extract of Averrhoa carambola was used for testing preliminary 
phytochemical screening in order to detect major chemical groups. 
Test for carbohydrates 
 Molisch’s test: Dissolved small quantity of 300mg alcoholic and dried leaf extract 
powder of Pimenta dioica separately in 4ml distilled water and filtered. The filtrate was 
subjected to Molisch’s test.  
 Fehling’s test: Dissolve a small portion of extract in water and treat with Fehling’s 
solution. 
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 Phenols test: The extract was spotted on a filter paper. A drop of phosphomolybdic 
acid reagent was added to the spot and was exposed to ammonia vapours. 
Test for flavanoids  
 Shinoda test: To 2 to 3ml of extract, a piece of magnesium ribbon and 1ml of 
concentrated HCl was added. 
 .Lead acetate test: To 5ml of extract 1ml of lead acetate solution was added.  
Test for tannins 
 Braemer’s test: To a 2 to 3ml of extract, 10% alcoholic ferric chloride solution was 
added. 
Test for steroid/terpenoid 
 Liebermann-Burchardt test: To 1ml of extract, 1ml of chloroform, 2 to3ml of acetic 
anhydride and 1 to 2 drops of concentrated Sulphuric acid are added. 
Test for alkaloids 
.Draggendorf’s test: A drop of extract was spotted on a small piece of precoated TLC plate 
and the plate was sprayed with modified Draggendorf’s reagent.  
 Hager’s test: The extract was treated with few ml of Hager’s reagen. 
 Wagner’s test: The extract was treated with few ml of Wagner’s reagent. 
Tests for Glycosides 
 Legal’s test: Dissolved the extract [0.1g] in pyridine [2ml], added sodium 
nitroprusside solution [2ml] and made alkaline with Sodium hydroxide solution. 
Test for Saponins 
 Foam test: 1ml of extract was dilute with 20ml of distilled water and shaken with a 
graduated cylinder for 15 minutes. 
Test for Anthraquinones 
 Borntrager’s test: About 50 mg of powdered extract was heated with 10% ferric 
chloride solution and 1ml of concentrated HCl. The extract was cooled, filtered and the 
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filtrate was shaken with diethyl ether. The ether extract was further extracted with strong 
ammonia. 
Test for Amino acids 
 Ninhydrin test: Dissolved a small quantity of the extract in few ml of water and 
added 1ml of ninhydrin reagent. 
Test for fixed oils and fats 
 Press small quantity of the petroleum ether extract between two filter paper. 
            Note: the results for the above experiments can be noted as follows. 
 If the response to the test is high it can be noted as +++which indicates that the  
particular group is present as the major class. 
 If the response is average then note it as ++ indicates the presence in moderate 
quantity. 
 If the response is very small then note it as + indicating the presence of only in 
traces. 
 If no response is then negative. 
 
E) Acute toxicity study 
 In a research study when a drug is administered to a biological system there will be 
some interactions may happen .In most case these are desired and usefull,but many effects 
are not advantageous. Acute, subacute and chronic toxicity studies are performed by the 
manufacturers in the investigation of a new drug.Acute toxicity is involved in estimation of 
LD50(It is the lethal dose (cuasing death)to 50% of tested group animals)
54. 
LD50 (median lethal oral dose) 
LD 50 (median lethal oral dose) is a statistically derived oral dose of a substance that 
can be expected to cause death in percent of animals when administered by the oral 
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route.The LD50 value is expressed in terms of weight of test substance per unit weight of 
animal(mg/kg) 
  In this study acute toxicity study was carried out in wistar albino rats.The 
procedure was followed by using OECD 423(Acute toxic class method).The rats are fasted 
overnight, prior to dosing. The three dose levels are administered by the help of oral 
feeding needle over the prior of 24 hours.After the drugs has been administered,food may 
be with held for a further 3-4 hours in rats.The purpose of sighting study is to allow 
selection of the appropriate starting dose for main study.The test substabce is administered 
to a single animal in a sequential manner following from the fixed dose levels of 5,50,300 
and 2000mg/kg. The interval between dosing of each level is determined by the 
mortality/onset,duration and severisty of toxic signs over the period of 24 hours,special 
attention given during the first 4 hours.Four hours after the drug administration,provide the 
food and water for 14 days and daily observed some parameters such as food intake,water 
intake,mortality,onset,Duration and severity of toxic signs.The animal weight is recorded 
on weekly once.On the day fourteen all the animals are sacrificed,to isolate the organs and 
observe the histopathological changes.Based on the mortality result of sighting is decided 
and carried out with five animals per dose level (5 or 50 or 300 or 2000mg/kg).Based on 
the mortality result on 14th day of observation,the doses for invivo study are selected.  
F) Invitro antidiabetic activity  of Averrhoa carambola leaf extracts 
Alpha-amylase inhibition assay 
Chemicals or reagents 
Potato starch, trichloroacetic acid, Folin-Ciocalteau reagents were purchased from 
SD Fine Pvt. Ltd., Mumbai, 3,5-dinitrosalicylic acid, Tris buffer, linoleic acid, ammonium 
molybdate, were purchased from Hi-Media Pvt. Ltd., Mumbai, α-amylase, α-glucosidase 
enzymes, xanthine oxidase, quercetin, hypoxanthine, pyrocatechol were purchased from 
SRL Pvt. Ltd., Mumbai. Glucose assay kit from Agappe diagnostic Pvt. Ltd., Kerala, 
Acarbose was obtained from Bicon Pvt. Ltd., Chennai, ferrozine, (2'2-azobis (2-amidino 
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propane) dihydrochloride), butylated hydroxy toluene from Loba Cheme. All other 
chemicals used in the study were obtained commercially and were of analytical grade. 
Instrument used 
UV-visible Spectrometer (Systronic double beam- UV-2201). 
Preparation of extract 
Leaf extractions used in invitro and invivo studies were prepared by using suitable 
solvents (Carboxy methyl cellulose). 
Experimental procedure for α-amylase inhibition assay 
A total of 500 µl of test samples and standard drug (100-1000µg/ml)  were 
added  to  500  µl  of  0.20  mM  phosphate  buffer  (pH  6.9)  containing  α-amylase 
(0.5mg/ml) solution and were incubated at 25°C for 10 min. After these, 500 µl of 
a 1% starch solution in 0.02 M sodium phosphate buffer (pH 6.9) was added to 
each tube. The reaction mixtures were then incubated at 25°C for 10 min. The 
reaction was stopped with 1.0 ml of 3, 5 di nitro salicylic acid colour reagent. The 
test tubes were then incubated in a boiling water bath for 5 min, cooled to room 
temperature. The reaction mixture was then diluted after adding 10 ml distilled 
water and absorbance was  measured  at  540  nm.  Control  represent  100%  
enzyme  activity  and  were 
conducted in similar way by replacing extract with vehicle. 
Calculation of 50% inhibitory concentration (IC50) 
The concentration of the plant extracts required to scavenge 50% of the 
radicals (IC50) was calculated by using the percentage scavenging activities at five 
different concentrations of the extract. Percentage inhibition (I %) was calculated by 
(Ac-As) 
I %  =       ---------------  x 100 
Ac 
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where, 
Ac      =   Absorbance of the control,  
As   = Absorbance of the sample. 
G) Invivo ( antidiabetic  a c t i v i t y )  of Averrhoa carambola leaf extract in 
STZ induced diabetic wistar albino rats. 
Wistar albino rats (150- 200 grams) of both sexes were procured from Sura 
(labs, Ameerpet, hyderabad, India.)  Prior to the experiment the rats were housed in a 
clean polypropylene cages (6 rats/ cages) for a period of 7 days under standard 
temperature (25 - 30o  c) , relative humidity (45 – 55%), dark / light cycle (12 /12 
hrs). The studies were performed with the approval of Organisational Animal Ethics 
Committee (OAEC)  (ULSB/DAEC/KER/678/333/17).  The animals were put in 
overnight fasting were deprived of food for 16 hrs but allowed free access of water. 
Treatment Protocol 
S.no Group Treatment 
1. Control (cmc) Received only CMC 
2. Positive control(cmc) STZ 
3. Extrat 200 of Averrhoa carambola Ethanolic extract of Extrat 200 of 
Averrhoa carambola 
4. Extract 400 Averrhoa carambola Ethanolic extract of Extrat 400 of 
Averrhoa carambola 
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Statistical Analysis 
 All values are expressed as mean ± SEM. Statistical analysis was performed by 
One-way Anova followed by Dunnet’s t-test using SPSS version 17. A ‘p’ value less than 
0.05 was considered significant. 
Research Outcomes 
Study of antidiabetic activity of an albino rat model as significant improvement was 
observed 
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6. RESULTS AND DISCUSSION 
A) Appearance and percentage yield of EEHC(Ethanolic Extract of Averrhoa 
carambola leaves) 
 Ethanolic extract of Averrhoa carambola was a semisolid brownish colour extract and the 
percentage yield was found to be 14.35%. 
B) Phytochemical studies 
S.No Compounds Testing Inferences 
  
Carbohydrates 
 
Molisch’s test 
Fehling’s test 
 
 
- 
  
Phenols 
 
Phosphomolybdic acid test 
 
+++ 
  
Flavonoids 
 
Shinoda test 
Lead acetate test 
 
 
++ 
++ 
  
Tannins 
 
Braemer’s test 
 
_ 
  
Alkaloids 
Wagner’s 
Mayer’s 
Draggendrof’s test 
+ 
+ 
+ 
  
Glycosides 
Legal’s test 
Brontranger’s test 
+ 
+ 
+ 
  
Saponins 
 
Foam test 
 
+ 
  
Sterols 
 
Salkowski’s test 
 
_ 
  
Amino acids 
 
Ninhydrin test 
 
_ 
  
Terpenoids 
 
Lieberman Burchardt test 
 
+ 
                         Table 8. Results of ethanolic extract of Averrhoa carambola 
+ In traces 
++ Present in moderate amount 
+++ More amounts is present 
-Absence 
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 The phytochemical studies results revealed that the Molisch’s test no characteristic 
observation indicated the absence of carbohydrates, by phosphomolybdic acid test Blue 
coloration of the spot indicated the presence of phenols. Shinoda test and Lead acetate test 
gave pink or red coloration of the solution indicated the presence of flavonoids Flocculent 
white precipitate also indicated the same. There is no dark blue or greenish grey coloration 
of the solution indicated the absence of of tannins in the drug. No characteristic observation 
for steroids and dark pink or red coloration of the solution indicated the presence of 
terpenoids. Orange coloration of the spot indicated the presence of alkaloids. Yellow or 
reddish brown precipitation precipitation indicated the presence of alkaloids. Pink to red 
colour solution indicates the presence of glycosides. No layer of foam formation indicates 
the absence of Saponins. If the response to the test is indicated table-1high it can be noted 
as++++ or +++ which indicates that the particular group is present as the major class. If the 
response is average then note it as ++ indicates the presence in moderate quantity and note 
it as + indicating the presence of only in traces. If no response is then negative.   
C)  Acute Toxicity  
      Acute toxicity study result shows that there is no morbidity and modality at 2000mg/kg 
animal body weight. Hence it can be used for clinical utility.     
  
D) invitro antidiabetic study     
Table 4. α-Amylase Inhibition of Petroleum Ether extract of   Averrhoa carambola 
leaves 
Conc (mcg/ml) Percentage Inhibition 
0 0 
25 34 
50 39 
75 46 
100 58 
125 62 
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Alpha-Amylase Inhibition of Petroleum Ether extract
of   Averrhoa carambola leaves
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Fig 8. Alpha-amylase Inhibition of Petroleum ether extract of Averrhoa 
carambola leaves 
 
Alpha-Amylase Inhibition of Petroleum Ether extract
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Fig 9. Graphical representation of Alpha-amylase Inhibition of Petroleum 
ether extract of Averrhoa carambola leaves 
 
Department Of Pharmacology, Karpagam College Of Pharmacy     Page 44 
 
Conc (mcg/ml) Percentage Inhibition 
0 0 
25 40 
50 47 
75 53 
100 61 
125 66 
          
Table 5. α-Amylase Inhibition of  Ethyl acetate Extract ofAverrhoa carambola 
leaves 
Alpha-Amylase Inhibition of  Ethyl acetate  extract
of   Averrhoa carambola leaves
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Fig 10. Alpha-amylase Inhibition of Ethyl acetate extract of Averrhoa 
carambola leaves 
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Alpha-Amylase Inhibition of Ethyl acetate  extract
of   Averrhoa carambola leaves
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Fig 11. Graphical representation of Alpha-amylase Inhibition of Ethyl 
acetate extract of Averrhoa carambola leaves 
 
Conc (mcg/ml) Percentage Inhibition 
0 0 
25 34 
50 40 
75 53 
100 60 
125 68 
         
Table 6. α-Amylase Inhibition of  Ethanolic Extract of Averrhoa carambola  
leaves 
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Alpha-Amylase Inhibition of  Ethanolic  extract
of   Averrhoa carambola leaves
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Fig 12. Alpha-amylase Inhibition of Ethanolic extract of Averrhoa 
carambola leaves 
Alpha-Amylase Inhibition of  Ethanolic  extract
of   Averrhoa carambola leaves
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Fig 13. Graphical representation of Alpha-amylase Inhibition of Ethanolic 
extract of Averrhoa carambola leaves 
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                    Table 7. α-Amylase Inhibition  of Acarbose  (Positive control)  
  
Alpha-Amylase Inhibition of  of Acarbose  (Positive control)
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Fig 14. Alpha-amylase Inhibition of positive control 
 
 
 
 
Conc (mcg/ml) Percentage Inhibition 
0 0 
25 30 
50 49 
75 60 
100 63 
125 73 
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Alpha-Amylase Inhibition of  of Acarbose  (Positive control)
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Fig 15. Graphical representation of alpha-amylase Inhibition of positive 
control 
 
 PERCENTAGE OF INHIBITION 
Extract % of Inhibition 
Petroleum ether Extract 62% 
Ethyl acetate extract 66% 
Ethanolic extract 68% 
Acarbose 73% 
                   
Table 8. Percentage Of Inhibition 
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Fig 16. % of inhabitation of  Alpha-amylase 
Invitro Antidiabetic studies result revels that 125 mcg of all extract shown the 
significant alpha-amylase Inhibition when compare with other concentration. In vitro α 
amylase studies result revels that increased concentration of all the extract has been shown 
significant inhibition of α amylase activity hence its dose depend manner.   Among all the 
Extract Ethanolic Extract shown the 68% of Inhibition of α Amylase which similar that of 
acarbose (standard) 73% of Inhibition of α Amylase. 
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Anti Diabetic Study 
Table 9. Hypoglycemic Test 
   The glucose levels were analysed by using glucometer and each value is the mean ±     
standard error (n= each group consist of 6 animals)(p<0.05)*, (p<0.001)**&                                             
(p<0.0001)*** as compared to control & positive control group evaluated by one             
way, ANOVA followed by Dunnet ‘t’ test. (CMC= Carboxy methyl Cellulose) 
Treatment 
Dose 
mg/kg 
Blood Glucose Level (mg/dl) 
0 min 0.5hr 1 hr 
Control (CMC) 0.5 % 67.26±2.51 67.88±1.96 70.56±0.43 
Positive Control 
Glibenclamide 2 67.20±0.04 51.43±1.94 30.29±0.33 
Ethanolic Extract of 
Averrhoa Carambola 
200 67.00±0.32 52.10±2.56 33.90±0.15 
Ethanolic Extract of 
Averrhoa Carambola 
400 67.80±0.24 59.32±1.26 58.76±1.43 
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Fig 17. Hypoglycemic effect initia 
 
Hypoglcemic effect 30 minutes
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Fig 18. Hypoglycemic effect 30 minutes 
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Hypoglcemic effect at 1 hour
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Fig 19. Hypoglycemic effect 1 hour 
The hypoglycemic test results have shown Table No:09 which indicated   ethanolic 
extract of Averrhoa carambola treated animals 200 & 400,  significantly decreased in 
blood glucose level (33.90±0.15 & 58.76± 1.43) (P<0.05)*, (P<0.001)**&  (P<0.0001)*** 
when compared to control and positive control. 
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Invivo antidiabetic study 
 
Sl. 
No. 
 
 
 
Treatment 
 
Blood glucose level (mg/dl) day 
Day    1 Day 7 Day 14 
1 Normal control 
10 ml/kg P.O 
80.56±1.43 76.32±1.65 77.62± 0.26 
2 Negative control 
100 mg/kg I.P 
268.60±0.97 276.34±0.85 279.02±0.23 
3 Positive control 
(Glibenclamide 2mg/kg)  
259.32±0.43 182.41±0.29 120.30±0.41 
4 Ethanolic Extract of 
Averrhoa carambola 
leaves 200 mg/kg  
263.04±1.51 257.56±0.42 250.1±1.38 
5 Ethanolic Extract of 
Averrhoa carambola 
leaves 400 mg/kg  
272.09±0.36 180.55±1.45 169.21±0.04 
 
Table 10. Results of the effects of ethanolic extract on blood Glucose levels 
(The values were expressed as Mean ± S.E.M. (n=6 animals in each group). 
The experimental results have indicated on table No:10. The negative control 
group glucose levels were significantly increased when compared to each other groups. 
All the groups of animals were affected in diabetes, which indicated blood glucose levels 
were slight changes in the blood glucose level  for normal control group at 7th and 14th 
days . On day 7th glucose levels were significantly decreased glibenclamide 2mg/kg 
treated group when compared with control group at 7th and 14th days. The ethanolic 
leaves extract of Averrhoa carambola treated groups 200 & 400 mg/kg were dose 
dependent manner decreased when compared  with control group but positive control 
have more anti diabetic activity  at 7th day.  The ethanolic leaves extract of Averrhoa 
carambola at the dose level 400mg/kg have equipotent activity when compared with 
positive control at 7th day. The ethanolic leaves extract of Averrhoa carambola 200 & 
400 mg/kg have been expressed dose dependent anti diabetic action when compared to 
control and positive control. On day 14th, ethanolic leaves extract of Averrhoa carambola 
treated animals 200 & 400 mg/kg significantly decreased and maintain the blood glucose 
level when compared to control and positive control. 
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Results of the effects of ethanolic extract on
 blood Glucose levels at day 1
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Fig 20. Results of the effects of ethanolic extract on blood Glucose levels at day 1 
 
Results of the effects of ethanolic extract on
 blood Glucose levels at day 7
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Fig 21. Results of the effects of ethanolic extract on blood Glucose levels at day 7 
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Results of the effects of ethanolic extract on
 blood Glucose levels at day 14
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Fig 22. Results of the effects of ethanolic extract on blood Glucose levels at day 14 
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Treatment 
Dose 
mg/kg 
Blood Glucose Level (mg/dl) 
0 min 0.5hr 1 hr 1.5hr 2 hr 2.5hr 3hr 
Control 
(CMC) 
0.5 % 69.29±0.39 146.73±0.05 191.49±0.64 176.62±0.23 161.03±2.68 158.03±2.25 133.41±3.30 
Positive 
Control 
Glibenclam
ide 
2 69.12±0.32 109.42±3.55 116.60±5.50 99.59±1.04 87.42±1.29 81.02±0.58 79.01±0.32 
Ethanolic 
Extract of 
Averrhoa 
carambola 
200 70.45±2.32 134.02±1.04 153.72±0.26 143.03±0.03 132.50±0.03 117.05±0.06 116.03±2.37 
Ethanolic 
Extract of 
Averrhoa 
carambola 
400 70.23±2.429 120.42±1.62 127.3±0.36 108.38±0.43 97.09±0.54 91.53±0.03 
 
89.04±0.43 
 
               
                                                                                  Table 11 - Oral Glucose Tolerance Test  
                                                                                                                                                                                                                              
The glucose levels were analyzed by using glucometer and all values are expressed as Mean±SEM (n=6), Group 2 was compared with  
               group 1, Groups —3,4 were compared with group 2; *p<0.05, **p<0.01,p<0.001*** evaluated by one way, ANOVA followed by  
               Dunnet ‘t’ test. 
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Fig.23 OGTT initial 
 
Oral Glucose Tolerance Test at 0.5 hour
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Fig 24. OGTT  30 minutes 
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Oral Glucose Tolerance Test at 1 hour
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Fig 25. OGTT  one hourly 
 
 
Oral Glucose Tolerance Test at 1.5 hour
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Fig 26. OGTT 1.5 hourly 
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Oral Glucose Tolerance Test at 2.0 hour
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Fig 27. OGTT 2.0 hourly 
 
 
Oral Glucose Tolerance Test at 2.5 hour
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Fig 28. OGTT 2.5 hourly 
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Oral Glucose Tolerance Test at 3.0 hour
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Fig 29. OGTT 3.0 hourly 
 
Oral Glucose Tolerance Test (OGTT) results have been expressed, half hour 
after the glucose treatment, all the groups of animal blood glucose levels were 
significantly increased. The blood glucose levels were significantly decreased for ,  
(aqueous) ethanolic extract of Averrhoa carambola 200 & 400 mg/kg 
(116.03±2.37↓& 89.04±0.43↓ ) ↓), (P<0.001) **& (P<0.0001) ** when compared to 
control and positive control at 1hour and each and every ½ hour blood glucose 
levels(200 mg/kg : (P<0.05)*, (P<0.001)**&  (P<0.0001)***  were changes in the 
dose dependent manner extract treated group of animals compared to control and 
positive control but 400mg/kg produce the equipotent activity 
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7.  SUMMARY  
            The leaf extraction was done by sequential extraction method the leaves of 
Averrhoa carambola using the solvent with increasing polarity order (petroleum ether, ethyl 
acetate and ethanol) and the active extract was tested by in vitro & in vivo antidiabetic 
screening method. The in vitro antidiabetic studies have been performed based on the α-
amylase inhibition assay. Each extracts were tested for α-amylase inhibition and the extract 
with minimum IC50 has been undergone phyto chemical screening. The procedure was 
followed by OECD maximum safe dose (2000mg/kg) were selected for further study. Finally 
the invivo antidiabetic activity of Ethanolic extract of Averrhoa carambola leaf was tested by 
using Streptozotocin induced diabetic rat. Acute toxicity study was carried out in rats. Fasting 
blood sample were drawn from retino orbital puncture of rats at weekly intervals till the end 
of the study 1,7 and 14 days. On these days fasting blood glucose were collected and 
analysed for glucose. At the end of the study (14th day) the ethanolic extract of Averrhoa 
carambola leaf (200mg/kg p.o and 400 mg/kg p.o) treated diabetic groups showed 
statistically significant decrease in blood glucose similar to the standard drug glibenclamide 
(2mg/kg), which indicated block the alfa amyalase activity and antagonize the Streptozotocin 
action.The present study suggested that the isolation of active constituents from ethanolic 
extract of Averrhoa carambola leaf and characterize the compounds by using preliminary 
phytochemical studies. 
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8. CONCLUSION 
In this current study, antidiabetic activity of both in vitro and in vivo has been 
studied for the Averrhoa carambola leaves, the ethanolic of higher concentration has 
shown the increased activity as compared with the standard drug and the control. 
Hence, the leaves of Averrhoa carambola has got the potential hypoglycaemic 
activity and can be safely used in diabetes induced animal model and it is less toxic 
even at higher concentration. Hence the glucose lowering activity of this Averrhoa 
carambola may be utilized for the treatment of type II diabetes mellitus. 
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